CCND1 and kidney cancer: FOXM1 is overexpressed in various human malignancies, including prostate, breast, lung, colon, stomach, liver, and kidney cancer, via the activation of Ras and cyclin D1 and FOXM1-depletion is sufficient to decrease carcinogenesis by stimulating apoptosis 45-47.